Literature DB >> 23740430

Rescue of deleterious mutations by the compensatory Y30F mutation in ketosteroid isomerase.

Hyung Jin Cha1, Do Soo Jang, Yeon-Gil Kim, Bee Hak Hong, Jae-Sung Woo, Kyong-Tai Kim, Kwan Yong Choi.   

Abstract

Proteins have evolved to compensate for detrimental mutations. However, compensatory mechanisms for protein defects are not well understood. Using ketosteroid isomerase (KSI), we investigated how second-site mutations could recover defective mutant function and stability. Previous results revealed that the Y30F mutation rescued the Y14F, Y55F and Y14F/Y55F mutants by increasing the catalytic activity by 23-, 3- and 1.3-fold, respectively, and the Y55F mutant by increasing the stability by 3.3 kcal/mol. To better understand these observations, we systematically investigated detailed structural and thermodynamic effects of the Y30F mutation on these mutants. Crystal structures of the Y14F/Y30F and Y14F/Y55F mutants were solved at 2.0 and 1.8 previoulsy solved structures of wild-type and other mutant KSIs. Structural analyses revealed that the Y30F mutation partially restored the active-site cleft of these mutant KSIs. The Y30F mutation also increased Y14F and Y14F/Y55F mutant stability by 3.2 and 4.3 kcal/mol, respectively, and the melting temperatures of the Y14F, Y55F and Y14F/Y55F mutants by 6.4°C, 5.1°C and 10.0°C, respectively. Compensatory effects of the Y30F mutation on stability might be due to improved hydrophobic interactions because removal of a hydroxyl group from Tyr30 induced local compaction by neighboring residue movement and enhanced interactions with surrounding hydrophobic residues in the active site. Taken together, our results suggest that perturbed active-site geometry recovery and favorable hydrophobic interactions mediate the role of Y30F as a secondsite suppressor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740430      PMCID: PMC3887930          DOI: 10.1007/s10059-013-0013-1

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  31 in total

1.  The rate of compensatory mutation in the DNA bacteriophage phiX174.

Authors:  Art Poon; Lin Chao
Journal:  Genetics       Date:  2005-05-23       Impact factor: 4.562

2.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

3.  Alteration of T4 lysozyme structure by second-site reversion of deleterious mutations.

Authors:  A R Poteete; D Rennell; S E Bouvier; L W Hardy
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

4.  A hydrogen-bonding network plays a catalytic role in photosynthetic oxygen evolution.

Authors:  Brandon C Polander; Bridgette A Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

5.  Solution structure of 3-oxo-delta5-steroid isomerase.

Authors:  Z R Wu; S Ebrahimian; M E Zawrotny; L D Thornburg; G C Perez-Alvarado; P Brothers; R M Pollack; M F Summers
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

6.  Crystal structure of delta(5)-3-ketosteroid isomerase from Pseudomonas testosteroni in complex with equilenin settles the correct hydrogen bonding scheme for transition state stabilization.

Authors:  H S Cho; N C Ha; G Choi; H J Kim; D Lee; K S Oh; K S Kim; W Lee; K Y Choi; B H Oh
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

7.  Interrupting the hydrogen bond network at the active site of human manganese superoxide dismutase.

Authors:  C A Ramilo; V Leveque; Y Guan; J R Lepock; J A Tainer; H S Nick; D N Silverman
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

8.  Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations.

Authors:  R K Brachmann; K Yu; Y Eby; N P Pavletich; J D Boeke
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

9.  High-resolution crystal structures of delta5-3-ketosteroid isomerase with and without a reaction intermediate analogue.

Authors:  S W Kim; S S Cha; H S Cho; J S Kim; N C Ha; M J Cho; S Joo; K K Kim; K Y Choi; B H Oh
Journal:  Biochemistry       Date:  1997-11-18       Impact factor: 3.162

10.  Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.

Authors:  Andreas C Joerger; Hwee Ching Ang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

View more
  4 in total

1.  Functional Rescue of Cataract-Causing αA-G98R-Crystallin by Targeted Compensatory Suppressor Mutations in Human αA-Crystallin.

Authors:  Ashutosh S Phadte; Sundararajan Mahalingam; Puttur Santhoshkumar; Krishna K Sharma
Journal:  Biochemistry       Date:  2019-09-20       Impact factor: 3.162

2.  Contribution of a low-barrier hydrogen bond to catalysis is not significant in ketosteroid isomerase.

Authors:  Do Soo Jang; Gildon Choi; Hyung Jin Cha; Sejeong Shin; Bee Hak Hong; Hyeong Ju Lee; Hee Cheon Lee; Kwan Yong Choi
Journal:  Mol Cells       Date:  2015-05-07       Impact factor: 5.034

3.  Structure of putrescine aminotransferase from Escherichia coli provides insights into the substrate specificity among class III aminotransferases.

Authors:  Hyung Jin Cha; Jae-Hee Jeong; Catleya Rojviriya; Yeon-Gil Kim
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

4.  Crystal structure of SgcJ, an NTF2-like superfamily protein involved in biosynthesis of the nine-membered enediyne antitumor antibiotic C-1027.

Authors:  Tingting Huang; Chin-Yuan Chang; Jeremy R Lohman; Jeffrey D Rudolf; Youngchang Kim; Changsoo Chang; Dong Yang; Ming Ma; Xiaohui Yan; Ivana Crnovcic; Lance Bigelow; Shonda Clancy; Craig A Bingman; Ragothaman M Yennamalli; Gyorgy Babnigg; Andrzej Joachimiak; George N Phillips; Ben Shen
Journal:  J Antibiot (Tokyo)       Date:  2016-07-13       Impact factor: 2.649

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.